Contact
Please use this form to send email to PR contact of this press release:
Verona Pharma Completes Enrollment in Phase 2b Clinical Trial with Nebulized Ensifentrine in moderate-to-severe COPD
TO:
Please use this form to send email to PR contact of this press release:
Verona Pharma Completes Enrollment in Phase 2b Clinical Trial with Nebulized Ensifentrine in moderate-to-severe COPD
TO: